Interferons
Interferons (IFNs) are a group of signalling proteins that are produced and released from cells in response to viral infection and other stimuli such as normal and tumour cell survival and death. IFNs interact with specific cellular receptors, thereby promoting production of secondary messengers which leads to the expression of antiviral and immune modulatory genes. There are three groups of IFNs, Type I IFNs, Type II IFNs and Type III IFNs. Type I IFNs include IFN-alpha, -beta, -omega, -kappa and IFN-zeta. These are essential for regulating the immune response to viral infections. The Type II IFN group only includes IFN-gamma. IFN-gamma is a versatile cytokine that plays an essential role in halting proliferation of cells, immunoregulation and its pro-inflammatory effects for various aspects of the immune response. The Type III IFN family includes IFN-lambda 1/IL-29, IFN-lambda 2/IL-28A, IFN-lambda 3/IL-28B and IFN-lambda-4. Type III IFNs have similar properties to Type I IFNs. ELISA Genie provide an extensive range of ELISA kits for research on the Interferon family.
Interferon Family Receptors
Interferon Family Regulators
Interferon Family Signalling Molecules
- 4EBP1
- Akt
- Akt1
- Akt2
- Akt3
- CEBP alpha
- CEBP epsilon
- CREB
- CrkL
- eIF4E
- ERK1/ERK2
- ERK1
- ERK2
- Histone H3
- HLA-C
- IkB-alpha
- IkB-beta
- IkB-epsilon
- IKK beta
- IRS1
- IRS2
- Jak1
- Jak2
- MAPKAPK2
- MEK1/MEK2
- MEK1
- MEK2
- MKK3/MKK6
- MKK3
- MKK6
- Mnk Inhibitors
- MSK1/MSK2
- MSK1
- MSK2
- NFkB/IkB Activators
- NFkB/IkB Inhibitors
- NFkB1
- NFkB2
- p38
- p38 alpha
- p38 beta/MAPK11
- p38 gamma
- p38 delta
- p70 S6 Kinase
- p70 S6 Kinase beta
- PDK-1
- PI 3-Kinase p85 alpha
- PI 3-Kinase p110 beta
- PI 3-Kinase p110 gamma
- PI 3-Kinase p110 delta
- PI 3-Kinase p85 beta
- PKC delta
- PRAS40
- Rac1
- RelA/NFkB p65
- RelB
- c-Rel
- RPTOR
- STAT1
- STAT2
- STAT3
- STAT4
- STAT5a
- STAT5b
- STAT6
- TOR
- TSC2
- Tyk2
- Vav-1
Interferons Type I
Interferons Type II
Interferons Type III
Recent Posts
-
Rescuing Exhausted T Cells: A New Frontier in Cancer Immunotherapy
For decades, the fight against cancer has been a story of incremental gains. But what if we could fu …30th Nov 2025 -
Cellular Senescence in Cancer Immunotherapy: The Double-Edged Sword
Cellular Senescence in Cancer Immunotherapy: The Double-Edged Sword In the intricate world of cance …29th Nov 2025 -
The Brain's Sentinels: How Microglia Shape Neuroinflammation in Disease
The Brain's Sentinels: How Microglia Shape Neuroinflammation in Disease In the intricate landscape …28th Nov 2025